Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Phathom Pharmaceuticals (PHAT) Cost of Revenue (2023 - 2026)

Phathom Pharmaceuticals (PHAT) has disclosed Cost of Revenue for 4 consecutive years, with $12.0 million as the latest value for Q1 2026.

  • For Q1 2026, Cost of Revenue rose 222.13% year-over-year to $12.0 million; the TTM value through Mar 2026 reached $30.9 million, up 173.91%, while the annual FY2025 figure was $22.6 million, 183.44% up from the prior year.
  • Cost of Revenue hit $12.0 million in Q1 2026 for Phathom Pharmaceuticals, up from $7.6 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $12.0 million in Q1 2026 and bottomed at $167000.0 in Q4 2023.
  • Average Cost of Revenue over 4 years is $4.3 million, with a median of $3.8 million recorded in 2024.
  • Year-over-year, Cost of Revenue soared 2184.43% in 2024 and then soared 100.47% in 2025.
  • Phathom Pharmaceuticals' Cost of Revenue stood at $167000.0 in 2023, then skyrocketed by 2184.43% to $3.8 million in 2024, then soared by 100.47% to $7.6 million in 2025, then soared by 56.85% to $12.0 million in 2026.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $12.0 million, $7.6 million, and $6.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.